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During medical school I had two employments in 2007 and in 2008-2009 at the 
Department of Endocrinology, Aalborg University Hospital. Here Professor Peter 
Laurberg introduced me to endocrine research and after I obtained my medical 
degree at Aarhus University in 2011, I was enrolled as a PhD student at Aalborg 
University on September 15, 2011. The main focus of my research has been on 
iodine status and thyroid ultrasonography. In this PhD thesis the implications of 
iodine fortification for the individual inhabitant of a population is addressed. 
Additionally, research on benign thyroid nodules examined with ultrasonography 
and ultrasound elastography has been of great interest and has resulted in one 
published and one submitted paper within this field. Throughout the years as a PhD 
student I have participated and presented my research at numerous national and 
international conferences. 
October 1, 2015 I will begin my medical internship at the Department of Acute 
Medicine, Aalborg University Hospital. 
 
 
 
 
 
SALT IODIZATION IN DENMARK AND INDIVIDUAL CHANGES IN THYROID SIZE, THYROID NODULARITY AND SERUM 
THYROGLOBULIN 
 
IV 
ENGLISH SUMMARY 
Background: Iodine is an essential mineral for the synthesis of thyroid hormones. 
Low iodine intake levels are associated with goitre and other iodine deficiency 
(ID)-related disorders that have affected billions of people worldwide. Until 
recently the iodine intake of many European populations, including the Danish, was 
below the recommended level and iodine fortification (IF) programs are 
internationally recommended to ensure sufficient iodine intake of the affected 
populations.  
Aim: The overall aim of this PhD thesis was to evaluate individual changes in 
thyroid related variables (thyroid volume, thyroid nodularity and serum 
thyroglobulin (Tg)) associated with a mandatory nationwide IF program.  
Methods: We performed a prospectively planned longitudinal population-based 
study (DanThyr) in two regions of Denmark with different iodine intake at baseline: 
Aalborg (moderate ID) and Copenhagen (mild ID). We examined 2,465 adult 
participants before (1997) and after (2008) the Danish mandatory IF of salt (2000). 
Results: Regional residence as a proxy of baseline iodine intake was of major 
importance for the individual changes observed in thyroid volume, thyroid 
nodularity and serum Tg. At follow-up the regional difference in urinary iodine 
concentration had disappeared. Correspondingly, the regional differences observed 
at baseline in both thyroid volume and serum Tg had levelled out at follow-up. 
Contradictory results were found regarding thyroid nodules where especially lower 
normalization rate of multiple nodules in Aalborg was evident. This may indicate 
that thyroid nodularity is more resistant to an increase in iodine intake compared 
with thyroid volume and serum Tg. At the follow-up investigation both regions 
were classified as mildly iodine deficient and median Tg among non-users of iodine 
containing supplements were higher than among iodine supplement users.  
Conclusions: The results of these investigations suggest that even small differences 
in baseline iodine intake play an important role for the effect of an IF program. 
Furthermore, our findings raise the question if a moderate increase in the level of 
iodine added to salt could be beneficial for the Danish population.  
 
 
V 
DANSK RESUME 
Baggrund: Jod indgår i dannelsen af stofskiftehormoner og et for lavt jodindtag er 
forbundet med struma og andre jodmangel sygdomme som har påvirket milliarder 
af mennesker verden over. Jodmangel har også været et problem i mange 
europæiske lande, inklusiv Danmark, og jodberigelsesprogrammer anbefales 
internationalt for at sikre sufficient jodindtag.  
Formål: Formålet med dette Ph.d. projekt var at undersøge individuelle ændringer i 
thyroidea relaterede variabler (thyroidea volumen, thyroidea knuder og serum 
thyroglobulin (Tg)) forbundet med et obligatorisk nationalt jodberigelsesprogram.  
Metode: Vi udførte et prospektivt planlagt longitudinelt populations-baseret studie 
(DanThyr) i to områder af Danmark med forskellig jodindtag ved baseline: Aalborg 
(moderat jodmangel) og København (mild jodmangel). Vi undersøgte 2.465 
personer både før (1997) og efter (2008) den obligatoriske jodberigelse af salt i år 
2000.   
Resultater: Niveauet af jodmangel før jodberigelsen viste sig at være af stor 
betydning for de individuelle ændringer vi observerede i både thyroidea volumen, 
thyroidea knuder samt serum Tg. Ved follow-up undersøgelsen var jodindtaget 
steget og den regionale forskel i jodindtag var forsvundet. Tilsvarende var de 
observerede regionale forskelle i thyroidea volumen og serum Tg også udjævnet 
ved follow-up. Undersøgelsen af thyroidea knuder viste modstridende resultater 
hvor specielt en lavere normaliserings rate af multiple knuder i Aalborg var tydelig. 
Dette kunne indikere at thyroidea knuder er mere resistente overfor et øget 
jodindtag end thyroidea volumen og serum Tg. Ved follow-up undersøgelsen blev 
begge områder klassificeret til at have mild jodmangel og median serum Tg hos 
deltagere der ikke tog jodtilskud lå højere end hos de deltagere der tog et jodtilskud. 
Konklusion: Vore resultater indikerer at selv små forskelle i jodindtag ved baseline 
har en stor og vigtig betydning for effekten af et jodberigelsesprogram. Derudover 
rejser vore fund spørgsmålet om hvorvidt den danske befolkning kunne have gavn 
af en moderat stigning i niveauet af jod der bliver tilsat salt. 
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CHAPTER 1. INTRODUCTION 
Iodine (I) is an essential mineral for the synthesis of thyroid hormones. Low iodine 
intake levels are associated with an increased risk of ID-related disorders (1-3) and 
have affected billions of people worldwide (4). Iodine is found in small amounts in 
many foods, but major sources are the marine food group, milk and dairy products 
and in some areas also drinking water (5).      
 
1.1. MEASURES OF IODINE STATUS IN A POPULATION 
Different methods can be used to measure the iodine status of a population. 
 
1.1.1. URINARY IODINE 
The majority of ingested iodine is absorbed as iodide (I-) in the gastrointestinal tract 
and finally at least 90 % is excreted in the urine (6). Therefore, UIC can be used as 
an indicator of recent (hours to days) iodine intake. However, iodine excretion 
varies considerably from day to day in an individual and UIC in a spot urine sample 
depends on fluid intake (7,8). Thus, UIC from solitary spot urine samples can only 
estimate the level of iodine intake in a population and not in an individual – unless 
repeated sampling is performed (9). Median UIC in spot urine samples is 
recommended by WHO, UNICEF and IGN as a measure of current iodine status in 
a population (10). The examined population is considered iodine deficient if the 
median UIC in the population is below 100 µg/l (Table 1-1). 
Table 1-1. Assessment of iodine nutrition in a population based on median urinary iodine 
concentration (UIC) of school-age children or non-pregnant and non-lactating adults (10). 
 
Iodine nutrition Median UIC (µg/l) 
Severe iodine deficiency < 20 
Moderate iodine deficiency 20-49 
Mild iodine deficiency 50-99 
Optimal iodine nutrition 100-199 
More than adequate iodine intake 200-299 
Excessive iodine intake > 300 
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1.1.2. THYROID VOLUME 
Thyroid gland size and goitre rate is used as a measure of long-term (months to 
years) iodine status in a population (10). Traditionally, thyroid size was determined 
by inspection and palpation. However, in mild to moderate iodine deficient 
populations the sensitivity and specificity of palpation are poor and thyroid volume 
measured by US is preferable (11). US provides a more precise measure of thyroid 
volume, but standardized techniques are essential to avoid systematic interobserver 
variation. 
 
1.1.3. THYROID NODULES 
According to WHO, UNICEF and IGN, thyroid nodule prevalence is not a 
recommended measure of iodine intake in a population (10). However, numerous 
studies have reported a high prevalence of thyroid nodules in iodine deficient areas 
compared to iodine sufficient areas (12). An association between thyroid nodules 
and median UIC seems evident and it could be speculated whether thyroid nodules 
prevalence could contribute as a measure of current and maybe previous iodine 
status in a population. 
 
1.1.4. SERUM THYROGLOBULIN 
Tg is a protein synthesized only in the thyroid gland (13) and serum Tg is well 
correlated with the severity of ID (14). Measurement of serum Tg is recommended 
as in indicator of a populations long-term iodine nutrition over a period of at least 
months (10). When comparing serum Tg levels, attention should be paid to the 
assays used for measuring serum Tg and to the presence of Tg-Ab, as these factors 
may influence the results (15). 
 
1.2. IODINE STATUS IN DENMARK 
In 1995 knowledge on the iodine status in Denmark was gathered by a group of 
experts in nutrition and thyroid diseases (16). They reported a high occurrence of 
goitre and hyperthyroidism among elderly people caused by autonomous thyroid 
nodules as well as a low UIC compared with the recommended levels. The iodine 
status in Denmark varied within the country corresponding to the content of iodine 
found in the drinking water (17-19). Eastern Denmark had a generally higher 
CHAPTER 1
content of iodine in the drinking water compared to western Denmark with the 
exception of Skagen where the drinking water had a high content of iodine
(Fig. 1-1).  
Fig. 1-1. Map of Denmark. The stippled
content of the Danish drinking water (17)
had higher iodine content than the drinking water in west
Belt. An exception was Skagen where the drinking water iodine 
observed in Denmark.  
To improve the Danish iodine status, a voluntary program of universal salt 
iodization (8 µg/g) was introduced in 1998
ineffective, and it was in the year 2000 replaced by a mandatory IF of household 
salt and salt in bread produced in Denmark (13 
chemical form of potassium iodide. 
A monitoring program entitled the Danish I
Thyroid Diseases (DanThyr) was initiated before any iodization of salt had begun
(20). This monitoring program was designed to improve knowledge on how to 
evaluate iodine status in a population
disorders in areas with different iodine intake 
increase in iodine intake. An important aim of monitoring was to secure that the 
. INTRODUCTION 
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 line illustrates the regional differences in the iodine 
. Overall, the drinking water in eastern Denmark 
ern Denmark, divided by The Great 
content was the highest 
 (20). This program turned out to be 
µg/g) (21). Iodine was added in the 
  
nvestigation on Iodine Intake and 
 
 and to evaluate the epidemiology of thyroid 
as well as to study the effects of an 
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program would not have unacceptable effects such as large increases in the 
occurrence of thyroid disorders. Previously, several countries experienced major 
increases in the incidence of hyperthyroidism after iodine fortification of salt (22). 
 
1.3. STUDY AIM 
The aim of this PhD thesis was to evaluate individual changes in thyroid related 
variables associated with IF. We chose thyroid volume, thyroid nodularity and 
serum Tg as indicators of impact and evaluated possible changes in an 11-year 
follow-up investigation performed before and after the mandatory IF in two regions 
with different iodine intake at baseline. The PhD thesis is a part of the Danish 
monitoring program, DanThyr. 
 
1.3.1. SPECIFIED STUDY AIMS 
Table 1-2. Specified study aims of the PhD thesis 
To assess the individual thyroid volume changes after a nationwide mandatory IF 
program in two areas with different iodine intake at baseline, and to clarify the 
main predictors of these changes (Paper I). 
To elucidate the relation between thyroid volume and ageing (Paper I). 
To assess the changes in thyroid gland structure at 11 years of follow-up after the 
introduction of a mandatory IF program (Paper II).  
To clarify how IF had influenced the natural history of thyroid nodules in two 
regions with different iodine intake at baseline (Paper II). 
To investigate individual changes in serum Tg in relation to IF and examine 
possible predictors of these changes (paper III). 
15 
CHAPTER 2. BACKGROUND 
2.1. IODINE AND THYROID VOLUME 
Iodine is an essential part of thyroid hormone synthesis and both ID (12) as well as 
iodine excess (23) is associated with an increase in thyroid volume. An assumed 
goitre genesis in ID is that a fall in the blood level of thyroxine, caused by the low 
level of iodide in the thyroid gland, leads to an increased output of TSH from the 
pituitary gland. TSH increases the uptake of iodide by the thyroid gland and the 
increased thyroid activity is associated with hyperplasia of the follicular thyroid 
cells and an increase in thyroid volume (24). However, iodine also has major effects 
on the thyroid independent of TSH (25).  
Various definitions of thyroid enlargement (goitre) have been used during the past 
century depending on the available methods to measure thyroid gland size. The first 
definitions were based on autopsy findings where studies often defined goitre as a 
thyroid gland exceeding 30-35 grams (12). Later, to allow investigation of people 
still alive, several definitions based on inspection and palpation of the thyroid gland 
were introduced. In the 1960s, thyroid US examinations began and different 
methods to calculate thyroid volume were introduced (26,27). This gave the 
opportunity of a much more precise thyroid volume measurement compared to 
inspection and palpation. Since the introduction of thyroid US examinations, the 
most commonly used goitre definition is a total thyroid volume exceeding the mean 
volume +3 SD in an iodine-replete population, corresponding to a total thyroid 
volume larger than 18 mL in women and 25 mL in men (28). 
 
2.2. IODINE AND THYROID NODULES 
While ID leads to an increased thyroid volume, it is also associated with an 
increased prevalence of thyroid nodules and nodular goitre (12). Several pathogenic 
models for this have been brought forward. E.g. the increase in TSH that may be 
seen in ID stimulates the follicular cells to proliferate. This stimulation is relatively 
weak and therefore only those follicular cells with a high growth potential will enter 
the meiotic circle and create new follicles. Follicular cells with high growth 
potential are not equally distributed within the thyroid gland resulting in nodule 
formation over time (29,30). Continued cell proliferation and nodule formation is 
associated with the appearance of activating TSH receptor mutations leading to 
thyroid nodules with autonomous hormone synthesis and secretion. Thus, nodule 
formation due to ID may give rise to both neck pressure symptoms as well as 
subclinical or overt hyperthyroidism. Another proposed model is that ID-associated 
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auto-regulation of thyroid activity leads to an increase in thyroid H2O2 production 
and that this is a main cause of mutations and nodularity (25,31-33). Both models 
could play a role in severe and moderate ID but in mild ID an increase in serum 
TSH is limited or absent (8) and the main driving force behind thyroid cell mutation 
may be the ID-associated auto-regulation.   
The high frequency of autonomous thyroid nodules among people living in iodine 
deficient areas is of concern when implementing a IF program since an increase in 
iodine intake may induce transient hyperthyroidism in those individuals, 
presumably because of the increased substrate available for thyroid hormone 
synthesis (22). The high prevalence of thyroid nodules in an iodine deficient 
population also presents a clinical challenge in the differential diagnostic between 
benign and malignant thyroid nodules. Because of the increased use of thyroid 
imaging more thyroid nodules are found. Current international guidelines 
recommend follow-up visits with US examination of presumably benign thyroid 
incidentalomas (34) and recent studies suggest that also benign nodules can look 
suspicious on US making the challenge for the clinicians even bigger (35-37).   
 
2.3. IODINE AND SERUM THYROGLOBULIN 
Tg is a 660 kDa protein synthesized exclusively by the thyroid follicular cells. In 
the thyroid follicle Tg plays a central role as a matrix in the synthesis and storage of 
thyroid hormone (Fig. 2-1). Previously it was assumed that Tg did not leave the 
thyroid gland, but in the 1960s Tg was identified in both monkey and human serum 
by a new sensitive radio-immunoassay method (38,39). Further studies investigated 
circulating Tg, and in the 1970s the association between high mean serum Tg and 
endemic goitre was described (40). Later, more studies confirmed and extended the 
results (41-44) while radio-immunoassays and screening for Tg-Ab were improved 
(45).  
The inverse relation between iodine intake and serum Tg is well established. The 
mechanism behind the high level of serum Tg in an iodine deficient population is 
thought to be high thyroid activity as part of the iodine auto-regulation as well as a 
greater thyroid cell mass, since the increased amount of Tg released to the blood 
positively correlates with thyroid volume (46). 
 
CHAPTER 2
Fig. 2-1. Illustration of thyroid hormone synthesis
Tg is syntezised in the thyroid follicular cell and transported to the follicular colloid where it 
is stored. In the follicular lumen the thyrosine residues of Tg undergo iodination to produce 
mono- (MIT) and di-iodothyrosines (DIT) and after conjugation of these iodothyr
with Triiothyronine (T3) and Thyroxine (T4) 
part of thyroid hormone secretion Tg 
undergoes proteolyse to release T3 and T4
bloodstream (48). 
Serum Tg can be a challenge to measure since inter
and since results can be hampered by circulating Tg
individual, the immunometric assay (IMA) method will typically underestimate the 
serum total Tg level, whereas the radio
overestimate the serum total Tg level. This is of major importance when serum Tg 
is used in diagnosis and follow-up of
carcinoma (15). However, the impor
debatable (49). 
. BACKGROUND 
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 and storage in the thyroid follicle (47). 
osines Tg 
is stored as colloid in the follicular lumen. As 
is endocytosed into the follicular cell. Here Tg 
 and both T3, T4 and Tg is secreted into the 
-method differences are high 
-Ab (15). In a Tg-Ab positive 
-immunoassay (RIA) typically will tend to 
 individual patients with differentiated thyroid 
tance of Tg-Ab in population-based studies is 

CHAPTER 3.
3.1. STUDY DESIGN
The monitoring program DanThyr was initiated in 1997 and includes a number of 
cross-sectional and register studies 
sectional study (Cohort 1a (C1a)) was performed in 1997
implemented. A second cross-sectional study (Cohort 2 (C2)) was performed 4
years after IF. The monitoring program was designed for a later follow
after the iodization of salt (Cohort 1b (C1b))
design gave a unique possibility to observe the consequences of IF at an individual 
level. Additionally, data from C2 was included
III.  
Fig.3-1. Illustration of the DanThyr cohorts investigated before and after the Danish 
mandatory IF of salt. 
DanThyr was designed to observe the Danish population in two regions with mild 
(Copenhagen, eastern Denmark) and 
representing the national differences in iodine intake caused by different iodine 
content of the drinking water (17). 
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 METHODS 
 
(20). As illustrated in Fig. 3-1, the first cross-
-1998 before IF was 
-5 
-up of C1a 
 (Fig. 3-1). This planned longitudinal 
 in sub-analyses of paper I and paper 
 
moderate ID (Aalborg, western Denmark) 
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3.2. STUDY POPULATIONS 
The participants of the baseline study (C1a) were selected in specific age and sex 
groups. An overrepresentation of woman, and especially young women, was chosen 
due to the high frequency of thyroid abnormalities among women and the 
importance of adequate iodine intake during pregnancy. A group of men was 
selected to allow for between sex comparisons. The age and sex groups were: 
women before the childbearing age (18-22 years), in the childbearing age (25-30 
years), after the childbearing age, both pre- (40-45 years) and postmenopausal age 
(60-65 years) and men (60-65 years). All subjects living in the selected areas within 
the specific age and sex groups were identified in the national civil register where 
all Danish citizens are registered by a unique ten-digit number (n = 40,233). A 
computer program randomly selected 9,274 of these subjects to be invited for 
participation. In total, 4,649 subjects (50.1 % of those invited) participated in 
Cohort 1a, 2,429 in Copenhagen and 2,220 in Aalborg (50). Non-participants were 
asked to answer a short questionnaire concerning, among other things, previous 
thyroid disease. No significant difference was found between participants and non-
participant on hyper- or hypothyroidism whereas bias was found regarding self-
reported goitre (participants 5.9 % vs. non-participants 3.6 %, p < 0.001) (51).  
Participants of the C2 study were randomly selected in the same regions and in the 
same age and sex groups as in C1a, making the two cohorts directly comparable. A 
total of 3,570 subjects participated in the study (46.6 % of the invited), 1785 in 
Copenhagen and 1785 in Aalborg (52).  
The follow-up investigation C1b was carried out between February 2008 and 
February 2010 resulting in a mean follow-up time of 11.2 years (range 10.1-12.8 
years). As illustrated in Fig. 3-2, all 4,649 participants of the baseline C1a study 
were identified. During the follow-up period, 403 subjects had died and 72 subjects 
had emigrated out of the country leaving 4,174 subjects to be invited for 
participation in the follow-up study. The invitations were sent by letter and in case 
of no response only one further invitation was sent. In total, 2,465 subjects 
participated in the follow-up study (59.1 % of the invited). The examinations were 
performed at either Aalborg University Hospital or Bispebjerg University Hospital 
in the region of Copenhagen. At each hospital a team including a physician and a 
sonographer performed the examinations. The participants answered health, food 
frequency and food supplement questionnaires, gave blood and urine samples and 
had a thyroid US examination performed. In addition, a physical examination as 
well as an interview was carried out.  
Owing to the prospective design of DanThyr, it was possible to keep all procedures 
identical in all three cohorts. 
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Fig.3-2.Flowchart illustrates participants included in the final study population of Paper I, 
Paper II and Paper III.  
The Danish investigation on 
iodine intake and thyroid diseases
(DanThyr)
1997-1998
Cohort 1a
n = 4,649
Deceased n = 403
Emmigrated n = 72
Invited for 11-year follow-up
2008-2010
n = 4,174
Treated for thyroid disease n = 228
Missing values for thyroid disease n = 22
Missing values for thyroglobulin n = 38
Included in the analyses of
thyroglobulin
(Paper III)
n = 1,417
Thyroglobulin antibody > 20 kU/l n = 760
No participation n = 1,709
Full participation
Cohort 1b
n = 2,465 (59.1%)
Cohort 1b
n = 2,215
Included in the analyses of
thyroid volume
(Paper I)
n = 2,208
Missing values for thyroid volume n = 7
Missing values for thyroid nodules n = 7
Included in the analyses of
thyroid nodules
(Paper II)
n = 2,208
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3.1. URINARY IODINE CONCENTRATION IN THE COHORTS 
In the baseline C1a study, median UIC in Copenhagen was 68 µg/l (61 µg/l for non-
users of iodine supplements) and in Aalborg median UIC was 53 µg/l (45 µg/l) 
(50), classifying Copenhagen as mildly iodine deficient and Aalborg as moderately 
iodine deficient (10). 
In C2, median UIC had increased compared with C1a. In Copenhagen median UIC 
was 108 µg/l (99 µg/l for non-users of iodine supplements) and in Aalborg UIC was 
93 µg/l (86 µg/l) (52) making Copenhagen iodine sufficient and Aalborg mildly 
iodine deficient (10). 
In C1b, median UIC had decreased again. In Copenhagen median UIC was 84 µg/l 
(76 µg/l for non-users of iodine supplements) and in Aalborg it was 83 µg/l (73 
µg/l) (53) classifying both Copenhagen and Aalborg as mildly iodine deficient (10). 
 
3.2. ULTRASONOGRAPHY 
All US examinations were performed by the same two sonographers using the same 
US apparatus (Sonoline Versa Pro 7.5-MHz 70-mm linear transducer; Siemens, 
Germany) in C1a, C2 and C1b.  
Thyroid volume was calculated as length × depth × width × π/6 for each lobe (54). 
Thyroid enlargement was defined as a thyroid volume >18 mL for women and >25 
mL for men, corresponding to the mean + 3 SD in an iodine sufficient population 
(28).  
Thyroid nodules ≥ 5mm were registered and in the event of more than three nodules 
in one lobe, only the three largest nodules were registered. Thyroid gland structure 
was defined as diffuse when no nodules were registered, as solitary nodule when 
one nodule was registered and as multinodular when more than one nodules was 
registered. Thyroid nodules included solid nodules and partly cystic nodules, but 
not thin-walled cysts. Thyroid nodule size was defined as the largest diameter by 
US, and in case of multiple nodules, the diameter of the largest nodules was used. 
 
CHAPTER 3. METHODS 
23 
3.3. LABORATORY PROCEDURES 
Non-fasting blood and spot urine samples were collected between 8:00 AM and 5:30 
PM. Samples were kept frozen (-20 °C) and analysed in random order at the study 
end.  
 
3.3.1. URINARY IODINE 
UIC (µg/l) was measured by the Ce4+/As3+ method after alkaline ashing (55,56). 
The analytical sensitivity was 2 µg/l. The iodine laboratory is certified by the U.S. 
Center for Disease Control and Prevention’s EQUIP Program. 
 
3.3.2. SERUM THYROGLOBULIN 
In the baseline C1a study, serum Tg was measured with an immunoluminometric 
assay (LUMITEST, BRAHMS Diagnostica GmbH, Berlin, Germany) using a 
Stratec autoanalyzer  (STRATEC biomedical Systems AG, Birkenfeld, Germany). 
The assay’s effective working range was 1-500 µg/l. In 12 consecutive assays the 
inter-assay coefficient of variations (CVs) for samples with average Tg 
concentrations of 8, 45 and 154 µg/l were 6.8, 4.5 and 3.3%.  
In the C2 study and the follow-up C1b study, serum Tg was analyzed using an 
immunoflourescent assay (hTg KRYPTOR BRAHMS) with a functional sensitivity 
<0.8 ng/ml (information from manufacturer). In 115 consecutive assays the inter-
assay CVs for samples with average Tg concentrations of 3.3 and 50.5 µg/l were 
5.6 and 2.8 %.  
We found disagreement between the two methods and a linear regression model 
(Tg(follow-up)=1.487+0.693×Tg(baseline)) was used to adjust baseline (C1a) Tg to 
the assay used in the C2 study and in the C1b follow-up study. 
  
3.3.3. THYROGLOBULIN ANTIBODIES 
In C1a Tg-Ab were analyzed using RIA (DYNOtest, BRAHMS) with a functional 
sensitivity at 20 kU/l. In C2 and C1b Tg-Ab were measured with an 
immunoflourescent assay (anti-Tgn KRYPYOR, BRAHMS). We re-measured Tg-
Ab in 201 serum samples kept frozen from the baseline study with the new assay. 
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We found a high correlation (rs=0.94) and a Bland-Altman plot showed a high level 
of agreement between the two methods. Thus, a cut-off of 20 KU/l was used to 
indicate Tg-Ab positivity in C1a, C2 and C1b. 
 
3.4. STATISTICAL ANALYSES 
All data processing was done with the STATA version 11.0 (Stata Corp., College 
Station, Texas, USA). Two-sided p < 0.05 was considered statistically significant. 
The choice of statistical tests depended on the distribution of the outcome variable 
and on whether data were paired or unpaired. 
 
3.5. ETHICS 
The study protocols were approved by the Danish Ethics Committee (2-16-4-0001-
97 and VN 96/208mch and N-VN-19960208MCH, the Northern Danish Region 
Committee). The study was conducted in accordance with the Declaration of 
Helsinki, and all participants gave written informed consent.  
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CHAPTER 4. SPECIFIC STUDIES 
PERFORMED 
4.1. THYROID VOLUME (PAPER I) 
4.1.1. RESULTS 
Overall, the follow-up period saw an increase in median thyroid volume in 
Copenhagen (11.8-12.2 ml, p=0.001) and a borderline decrease in median thyroid 
volume in Aalborg (13.3-13.1 ml, p=0.07). Both regions witnessed an age-related 
trend in individual thyroid volume changes from baseline to follow-up: Thyroid 
volume increased in women <40 years of age and decreased in women >40 years of 
age (Fig. 4-1). In addition, multivariate logistic regression models found that higher 
age predicted a thyroid volume decrease and that women of higher age were less 
likely to have an increase in thyroid volume during follow-up. 
 
Fig. 4-1. Prevalence of thyroid volume decrease (-20%) and increase (+20%) according to 
female age groups at baseline.   
In analyses limited to women aged 30-32 and 40-42 years, we included data from 
the C2 study and compared geometric mean thyroid volume in female participants 
of C1a, C2 and C1b. In C1a, thyroid volume was higher among women aged 40-42 
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years than in women aged 30-32 years (14.5/12.3ml, p<0.001), whereas no 
difference was observed in C2 (11.8/11.4 ml, p=0.3) or in C1b (12.4/12.7 ml, 
p=0.5). 
In multivariate logistic regression models we found higher age and baseline thyroid 
enlargement to be predictors (p<0.05) of an individual thyroid volume decrease 
whereas baseline multinodularity and a family history of thyroid disease were 
predictors of a thyroid volume increase during the follow-up period. 
 
4.1.2. DISCUSSION 
During our follow-up study participants became 11 years older and had an increase 
in iodine intake. Thus, both age and iodine may have influenced thyroid volume in 
our participants. Previous studies performed in iodine deficient areas have 
described an increase in thyroid weight and volume with age (50,57,58). We 
observed an increase in thyroid volume among our youngest participants, which 
could be explained by them getting older. However, the oldest participants 
experienced a thyroid volume decrease despite getting older. Other studies 
performed in iodine sufficient areas suggested that thyroid volume may decrease 
with age (59,60). Thus, it could be speculated that iodine intake may influence the 
age-related variation in median thyroid volume. This notion was supported by our 
analyses restricted to women aged 30-32 and 40-42 years where median thyroid 
volume before IF was higher among the oldest women, whereas no difference in 
thyroid volume was observed after IF. But, if the increased level of iodine intake 
influenced the age-related change in thyroid volume towards a decrease, why did 
we then observe a thyroid volume increase among the youngest participants? We 
speculated if the increase in thyroid volume among the youngest women during the 
follow-up period could be associated with thyroid autoimmunity. To elaborate on 
this, we performed additional analyses of median thyroid volume among women 
aged 18-30 years at baseline and excluded participants positive for either Tg-Ab 
(Tg-Ab > 20 kU/l) or TPO-Ab (TPO-Ab >60 kU/l) at baseline, follow-up or both. 
These analyses showed the same results regardless of thyroid autoimmunity: an 
increased median thyroid volume at follow-up. Thus, thyroid autoimmunity does 
not seem to explain the thyroid volume increase found in the young female 
participants. Another explanation may be that the higher level of iodine intake had 
the largest impact on individuals exposed to ID in the longest period of time. Thus, 
the influence of IF would dominate the thyroid volume change in the oldest 
participants leading to a thyroid volume decrease whereas the age-related influence 
on the thyroid volume would dominate among the youngest participants leading to a 
thyroid volume increase (Table 4-1). This notion is supported by the observed 
regional difference in median thyroid volume: participants living in Aalborg had 
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been exposed to the highest level of ID which resulted in an overall (although not 
significant) thyroid volume decrease whereas participants from Copenhagen 
experienced an overall thyroid volume increase. 
Table 4-1. Table illustrating the theoretical influence of age and iodine on thyroid volume 
change in the youngest and the oldest female participants. 
 
Women 
Age-related 
thyroid volume change 
Iodine-related 
thyroid volume change 
Observed 
thyroid volume change                  
18-30 yrs  
 
 
40-65 yrs  
↓ 
 
 
 
4.2. THYROID NODULES (PAPER II) 
4.2.1. RESULTS 
The follow-up period observed an overall increased prevalence of multiple thyroid 
nodules mainly caused by an increased prevalence in Aalborg (Fig 4-1). However, 
when we took age into account and compared women aged 40 years at the first 
investigation (1997-1998) with women aged 40 years at the second investigation 
(2008-2010), we found a lower prevalence of both solitary (p=0.004) and multiple 
(p<0.001) nodules at the second investigation. 
Changes in thyroid structure during the follow-up period were common. One-third 
of solitary thyroid nodules identified at baseline had disappeared at follow-up and 
one-fifth of previous multinodular thyroid glands had a diffuse structure at follow-
up. Overall, we found regional differences in both incidence and normalization 
rates of thyroid nodules with higher incidence and lower normalization rates in 
Aalborg with the lowest baseline UIC. In addition, solitary nodules had a 
significantly higher normalization rate than multiple nodules (normalization rate 
ratio 0.47 (95%CI = 0.32-0.67). The analyses were repeated for nodules with a 
diameter > 10 mm and showed the same results.  
 
↑ 
↑ 
↓ ↑ 
↓ 
+ 
+ 
= 
= 
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Fig 4-2. Prevalence of thyroid nodules in Copenhagen and Aalborg at baseline (1997-1998) 
and at follow-up (2008-2010). 
***p<0.001 
 
4.2.2. DISCUSSION 
At the follow-up investigation both regions were classified as mildly iodine 
deficient. Thus, owing to the mandatory IF in year 2000, Aalborg had the highest 
increase in median UIC compared with Copenhagen during the 11-year follow-up 
period. Despite this increase Aalborg had higher nodule incidence rates and lower 
normalization rates. This may suggest that the former longstanding level of ID still 
had an impact on the changes in thyroid structure. The largest regional difference 
was found between the normalization rates of multiple nodules, whereas no 
significant regional difference was found among the normalization rates of solitary 
nodules. Furthermore solitary nodules had higher normalization rates than multiple 
nodules. This demonstrates the heterogeneity among thyroid nodules with a higher 
reversibility of solitary nodules and it may indicate a more limited effect of IF on 
multiple nodules compared with solitary nodules. The reason could be structural 
differences or it could be that the majority of solitary nodules identified in this 
study were in fact the beginning of a multinodular disease and therefore more likely 
to normalize compared with more severe multinodular disease.  
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Looking at the incidence and normalization rates of thyroid nodules we did not 
elucidate the actual growth or shrinkage of the individual nodule investigated. To 
explore this we performed additional analyses where we looked at the natural 
history of the 46 solitary nodules present at both baseline and follow-up: 20 solitary 
nodules in Copenhagen and 26 solitary nodules in Aalborg. Overall, the follow-up 
period saw a borderline increase in median nodule diameter (15.2-16.7 mm, 
p=0.05). When stratifying by region, a significant increase in median nodule 
diameter was found in Copenhagen (14.0-18.4 mm, p=0.004) whereas no 
significant change was observed in Aalborg (16.2-13.6 mm, p=0.99). Thus, even 
though the trend with higher incidence rates and lower normalization rates in 
Aalborg also applied to solitary nodules, a different pattern appeared when looking 
at solitary nodules present at both baseline and at follow-up. Nodule growth was 
only evident in Copenhagen, the region with the highest pre-iodization median UIC. 
These analyses were unadjusted, sample size was small, and the study has no 
control group, however, it could be speculated that it was the larger increase in 
iodine intake in Aalborg compared with Copenhagen that affected the thyroid 
nodules and lead to nodule growth in Copenhagen and insignificant change in 
nodule size in Aalborg. This notion is supported by a randomized placebo-
controlled trial of patients with thyroid nodules undergoing therapy with iodine 
(61). They found a significant reduction in nodular volume in patients treated with 
iodine alone compared with placebo. 
The conflicting results between incidence and normalization rates on the one hand 
and the natural history of solitary nodules on the other hand underline the diversity 
of thyroid nodules. Thyroid nodule heterogeneity of morphology, function and 
growth has previously been described in multinodular goitre (29) and an overall 
difference in growth pattern between the nodules investigated in general and the 
solitary nodules used for the analysis of natural history could explain the 
inconsistent findings. Additionally, a difference in nodule susceptibility to iodine 
may also play a role as well as the possibility that the majority of solitary nodules 
used in the analyses of incidence and normalization rates actually were the 
beginning of multinodular thyroid disease.  
 
4.3. SERUM THYROGLOBULIN (PAPER III) 
4.3.1. RESULTS 
During the 11-year follow-up period, median serum Tg had decreased in Aalborg 
(11.4/9.0 µg/l, p<0.001) whereas no change in median Tg was observed in 
Copenhagen (9.1/9.1 µg/l, p=0.67).  In addition, the region-related differences in 
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median Tg observed at baseline (Copenhagen/Aalborg, 9.1/11.4 µg/l, p<0.001) had 
disappeared at follow-up (Copenhagen/Aalborg, 9.1/9.0 µg/l, p=1.00).  
In a multivariate linear regression model, living in Aalborg (p<0.001) and not using 
iodine supplements at baseline (p=0.001) predicted an individual decrease in serum 
Tg whereas high age (p=0.003) was associated with an increase in Tg during the 
follow-up period. 
We found a higher median Tg among non-users of iodine containing supplements 
compared with iodine supplement users both before (11.2/8.1 µg/l, p<0.001) and 
after (9.4/7.9 µg/l, p<0.001) IF. A regional difference in median Tg was only 
significant among non-users of iodine supplements before IF (p<0.001). 
 
4.3.2. DISCUSSION 
Living in Aalborg (formerly moderate ID) was a strong predictor of a decrease in 
serum Tg compared with living in Copenhagen (formerly mild ID). Thus, the 
degree of baseline ID was very important for the individual change in serum Tg 
even though the difference in baseline UIC between Aalborg (53 µg/l) and 
Copenhagen (68 µg/l) was small.  Likewise, median serum Tg only decreased in 
Aalborg with the largest increase in UIC, which levelled out the regional 
differences found before IF. These findings corroborate the results of two previous 
randomized trials (44,62) that showed a close end sensitive relation between 
individual iodine supplement intake and their serum Tg level. 
Measuring serum Tg can be challenging and both the specific assay used and the 
Tg-Ab status of the individual is of major importance for a correct measurement 
(15). We excluded Tg-Ab positive participants from the analyses of this paper 
because Tg-Ab is known to influence the measurement of serum Tg. Though, a 
previous study suggested that exclusion of Tg-Ab positive participants may not 
influences the results of population-based studies (49). To explore this further we 
repeated our analyses of median serum Tg and included the Tg-Ab positive 
participants. As expected, this showed generally lower median Tg levels (Fig. 4-3). 
However, the results showed the same trends and did not change the overall 
conclusions. This is in accordance with Vejbjerg et al. (49) and could indicate that 
exclusion of Tg-Ab positive participants is not essential for the interpretation of 
population-based data. 
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Fig 4-3. A Median serum Tg (µg/l) (EXCLUDING Tg-Ab positive participants) at baseline 
and follow-up by age group at baseline in the two investigated regions Copenhagen and 
Aalborg (n=1,417). To assist visual comparison, a line (horizontal stippled) has been added 
corresponding to the lowest value of median Tg found at baseline in Copenhagen among 18-
22 year old women (Tg=7.2 µg/l). B Median serum Tg (µg/l) (INCLUDING Tg-Ab positive 
participants) at baseline and follow-up by age groups at baseline in the two investigated 
regions Copenhagen and Aalborg (n=2,177). To assist visual comparison, a line (horizontal 
stippled) has been added corresponding to the lowest value of median Tg found at baseline in 
Copenhagen among antibody-negative 18-22 year old women (Tg=7.2 µg/l). 
*p<0.05 **p<0.01 ***p<0.001 
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CHAPTER 5. GENERAL DISCUSSION 
5.1. STUDY COMPARISONS 
The three papers illuminate individual changes associated with a mandatory IF 
program. Overall, the small regional difference in baseline UIC played an important 
and dominating role for the investigated outcomes. Region predicted individual 
changes in all three studies although both regions were classified as mildly iodine 
deficient at follow-up. In paper I thyroid volume decreased in Aalborg and 
increased in Copenhagen and in Paper III serum Tg decreased in Aalborg whereas 
no change was observed in Copenhagen. These results could indicate that IF had the 
largest impact on those individuals who experienced the largest increase in UIC. 
However, when we investigated thyroid nodules (paper II) Copenhagen had the 
lowest incidence rates and highest normalization rates; and moreover, living in 
Copenhagen predicted thyroid nodule disappearance. Thus, the former longstanding 
level of ID appeared to have more impact on thyroid nodules than the actual 
increase in iodine intake during the 8 years after IF. These conflicting results were 
confirmed in the regression analyses performed in paper I. Here baseline thyroid 
enlargement predicted a thyroid volume decrease whereas baseline multinodularity 
predicted a volume increase, keeping in mind that regression towards the mean may 
explain some of the thyroid volume decrease seen in participants with baseline 
thyroid enlargement (63). Thus, although we found thyroid nodules to be a dynamic 
and not necessarily irreversible abnormality, these results may indicate that thyroid 
nodularity is more resistant to an increase in iodine intake compared with thyroid 
volume and serum Tg. A certain degree of iodine memory may be in action when it 
comes to thyroid nodules. Thus, thyroid structure abnormalities in a population may 
not only reflect the actual iodine intake but also previous iodine intake of the 
population (3). 
 
5.2. THE DANISH IODINE INTAKE 
After the commencement of the Danish mandatory iodization of table and bread salt 
there has been a clear increase in the populations UIC (Aalborg: 53 vs. 83 µg/l, 
Copenhagen: 68 vs. 84 µg/l) and both regions where at the follow-up investigation 
classified as mildly iodine deficient. However, despite this clear increase, UIC was 
lower than observed in the C2 study investigated 4-5 years after IF 
(Copenhagen:108 µg/l,  Aalborg: 93 µg/l) (52). A major reason for the observed 
decrease may be a reduction in the iodine content of common milk and dairy 
products (64) and this observation stresses the importance of persistent monitoring 
of fortification programs in order to ensure sustainable iodine sufficiency.  
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Corresponding to the general increase in iodine intake with the most prominent 
change in Aalborg, we found a reduction in the regional differences among the 
investigated outcomes compared with baseline. However, at the follow-up 
investigation we found median Tg among non-users of iodine containing 
supplements to be higher than among iodine supplement users. This finding 
together with the decrease in UIC since the C2 investigation raise the question if a 
moderate increase in the level of iodine added to the salt could be beneficial for the 
Danish population.  
 
The IF program initiated in year 2000 was cautious (13 µg/g) to reduce the risk of 
side effects (20) and WHO, UNICEF and IGN recommend that the level of iodine 
added to the salt should be within the range of 20-40 µg/g in order to provide 150 
µg of iodine per person per day (10). Even though the Danish IF was cautious, we 
found significant changes in the evaluated outcomes chosen as indicators of impact, 
and our findings emphasize that even small changes in iodine intake is of 
importance. Additionally, known side-effects to an increased iodine intake 
(22,65,66) have been observed in the Danish population despite the relatively low 
level of iodine added to the salt (67-69). Thus, a cautious approach in combination 
with continuous monitoring would be sensible. The aim of a modest increase in the 
amount of iodine added to salt could be to bring the median UIC to a level around 
100 µg/l as found in 2004-2005 (52). 
 
In 2012 a Danish investigation performed by Andersen et al. (70) found insufficient 
iodine intake among pregnant women in Aalborg. Pregnant women are extra 
vulnerable to iodine deficiency because their needs for iodine are higher and since 
thyroid hormone plays a crucial role in early brain development of the foetus (71). 
This finding elaborates and confirms our results indicating a need for a moderate 
increase in the Danish IF. If the level of iodine added to salt was increased, a 
concern could be an excessive iodine intake among children due to their relatively 
high consumption of milk. Another study by Andersen et al. (72) included 51 
children from Aalborg aged 1-14 years and found that median UIC in these children 
did not differ significantly from median UIC among the pregnant women. However, 
the number of children investigated in this study was limited and an actual 
investigation of schoolchildren in eastern Denmark may give the additional 
knowledge required to make an informed decision regarding an increase in the 
iodine level of the mandatory Danish IF of salt. 
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CHAPTER 6. METHODOLOGICAL 
CONSIDERATIONS 
6.1. STUDY DESIGN AND POPULATION 
The longitudinal design with examination of participants before and after IF gave a 
unique possibility to investigate individual changes associated with IF as well as 
identifying possible predictors of these changes. However, we have no control 
group (a group without IF) and therefore, no firm conclusions regarding causal 
relations between IF and the investigated outcomes can be drawn from this study. A 
few sub-analyses within Paper I and III included data from the cross-sectional study 
C2 and considered C1a, C2 and C1b as independent cohorts. Since C1b is a follow-
up investigation of C1a, they are not independent and therefore, this is a major 
limitation. A cross-sectional investigation with participants from the same regions 
and within the same age and sex groups as in C1a and C2 would give 
epidemiologically more precise information on the Danish iodine status.  
The long follow-up period resulted in a relatively low participation rate of 59.1%. 
This could introduce selection bias and participants did differ from non-participants 
on a few central variables. However, in Paper II we calculated inverse probability 
weights to account for missing at random and used these weights in our prevalence 
data as well as our regression models without any change in the results. Part of the 
study results can be difficult to interpret because participants of the follow-up study 
had become 11-years older. On the other hand, the long follow-up period allowed 
us to investigate structural changes that may developed over a long period of time 
such as changes in thyroid volume and nodularity. 
The study population included participants in specific age groups and consisted 
mainly of women. Therefore, we cannot generalize our results to the entire 
population although we have a relatively large study population.  
 
6.2. EXCLUDED FROM THE ANALYSES 
6.2.1. SUBJECTS TREATED FOR THYROID DISEASE 
We excluded participants treated for thyroid disease including those with current or 
previous treatment with medicine, surgery or radioactive iodine therapy from all 
analyses (n = 228). Exclusion took place both when therapy had been recorded at 
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baseline and at follow-up. Information on treatment for thyroid disease was 
registered after an interview with a physician and no validation on self-reported 
data was made. As may be expected, participants excluded based on treatment for 
thyroid disease differed significantly from the participants included in the final 
study population (Table 6-1).  
In this follow-up investigation we wanted to examine the general population and 
not thyroid patients. As depicted in Table 6-1, the participants treated for thyroid 
disease had higher thyroid volume, more thyroid nodules and were more frequent 
elderly women living in Aalborg. Thus, including them in our analyses could affect 
our results and cause an attenuation of the regional differences. 
 
Table 6-1. Baseline characteristics (C1a) of participants in the follow-up investigation (C1b) 
included in the final study population, and participants treated for thyroid disease and 
excluded from the final study population. Data represent n (%) and median (25th-75th 
percentiles). Comparisons were made using χ2-test for categorical variables and Mann-
Whitney’s U test for median of continuous variables.  
 Participants included 
in the final study 
population 
(n = 2237) 
Participants treated 
for thyroid disease 
 
(n = 228) 
 
p 
Age groups (years) 
  <0.001 
   Women, 18-22 468 (20.9) 21 (9.2)  
   Women, 25-30 488 (21.8) 26 (11.4)  
   Women, 40-45 585 (26.2) 72 (31.6)  
   Women, 60-65 290 (13.0) 91 (39.9)  
   Men, 60-65 406 (18.2) 18 (7.9)  
Region 
  0.002 
   Copenhagen 1,144 (51.1) 92 (40.4)  
   Aalborg 1,093 (48.9) 136 (59.7)  
Daily smoking 715 (32.0) 78 (34.2) 0.76 
Family history of thyroid 
disease 
437 (19.5) 70 (30.7) <0.001 
TPO-Ab ≥ 30 kU/l 276 (12.6) 115 (50.9) <0.001 
Thyroid volume (ml) 12.5 (9.5-17.0) 15.0 (10.0-25.1) <0.001 
Thyroid enlargement 
(>18/25 ml) 
479 (21.4) 91 (40.1) <0.001 
Multinodularity 223 (10.0) 56 (24.7) <0.001 
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6.2.2. SUBJECTS POSITIVE FOR TG-AB 
In paper III we excluded Tg-Ab positive (Tg-Ab>20 kU/l) participants because Tg-
Ab is known to influence the measurement of serum Tg (15). The participants 
positive for Tg-Ab did differ from the final study population on two central 
variables: More were women (87.9 vs. 78.3 %, p<0.001) and more were living in 
Aalborg (53.3 vs. 47.1 %, p=0.01). However, no difference was found in regard to 
iodine supplements (p=0.61), thyroid volume (p=0.69) or thyroid nodularity 
(p=0.50).  
 
6.3. CHANGE IN REGIONAL RESIDENCE 
In total 66 participants changed regional residence during the follow-up period and 
were as a result examined in the opposite region at the follow-up investigation. Five 
of these participants were treated for thyroid disease leaving 61 participants who 
changed regional residence to be included in the final study population (2.8 %). 
Table 6-2. Follow-up characteristics (C1b) of participants who were investigated in the same 
region at both baseline (C1a) and follow-up (C1b) (n=2,154) and participants who changes 
regional residence during the follow-up period (n=61) stratified by region at follow-up. Data 
represent n (%) and median (25th-75th percentiles). Comparisons were made using χ2-test for 
categorical variables and Mann-Whitney’s U test for median of continuous variables.  
 
Investigated in  
Copenhagen 
at follow-up 
Investigated in  
Aalborg 
at follow-up 
Follow-up 
variables 
No change in 
regional 
residence 
(n = 1,110) 
Change in 
regional 
residence 
(n = 46) 
p No change in 
regional 
residence 
(n = 1,044) 
Change in 
regional 
residence 
(n = 15) 
p 
Thyroid 
volume 
(ml)  
12.2 (9.6-15.8) 12.3 (9.1-14.8) 0.66 13.1 (10.0-18.5) 13.4 (12.1-18.3) 0.53 
Thyroid 
nodules   
318 (28.8) 9 (19.6) 0.17 362 (34.8) 4 (26.7) 0.51 
Serum Tg 
(µg/l) 
8.2 (4.8-14.6) 7.4 (4.0-12.9) 0.35 8.7 (4.9-15.1) 9.3 (3.8-14.1) 0.93 
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In additional analyses we found no difference in our three main outcome measures 
between participants changing regional residence and participants investigated in 
the same region at both investigations (Table 6-2). Only a small percentage changed 
residence and even though the negative results in these analyses may be due to lack 
of power, these participants were unlikely to influence our results. 
 
6.4. INTEROBSERVER VARIATION 
Thyroid examination by US is influenced by both intra- and interobserver 
variability (73). Therefore, well-defined measuring procedures and as few observers 
as possible are essential for the reproducibility and reliability of thyroid US 
examinations.  
To reduce variability in this follow-up study, US examinations were performed by 
the same two sonographers (one in each region) using the same equipment at both 
baseline and follow-up. An interobservational study was performed before the 
baseline investigation (54) and a confirmatory study was carried out before the 
follow-up investigation commenced. This showed a continued good correlation 
(r=0.95, p<0.001) between the two sonographers’ thyroid volume measurements.  
In paper I we assessed individual changes in thyroid volume and defined a change 
as a more than 20 % increase or decrease from baseline to follow-up by US.  Due to 
the long period of time between examinations we defined an individual change as 
twice the interobserver variability found by Knudsen et al. (54). 
Assessment of thyroid nodules by US is also associated with both inter- and 
intraobserver variability (54,74,75). We only included clearly defined thyroid 
nodules > 5 mm as recommended by Knudsen et al. (54) as micro-nodularity 
showed poor interobserver agreement. 
 
6.5. THYROGLOBULIN ASSAYS 
Two different methods were used for measuring serum Tg in the baseline and in the 
follow-up study. To investigate the level of agreement between the two methods we 
re-analysed 101 Tg-Ab negative serum samples kept frozen from the baseline study 
with the new assay and a Bland-Altman plot showed higher measured values with 
the baseline assay compared with the assay used at follow-up (Fig 6-1A). 
Therefore, a linear regression model was used to define the association between the 
two methods (Tg(follow-up)=1.487+0.693*Tg(baseline)) and this equation was 
CHAPTER 6. METHODOLOGICAL CONSI
used to adjust Tg measured at baseline to the ass
Adjusted baseline Tg was used in all analyses.
Fig 6-1. A Bland-Altman plot (x-axis: average of two measures, y
two measures) illustrating the level of agreement between the unadjusted assay used to 
measure Tg in the baseline study and the
negative serum samples from the baseline study were kept frozen and re
new assay. B Bland-Altman plot illustrating the level of agreement between the adjusted 
baseline assay (Tg(follow-up)=1.487+0.693*Tg(baseline)) and the new assay used in the 
follow-up study (n=101).  
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ay used at follow-up (Fig 6-1B). 
 
 
-axis: difference between 
 new assay used in the follow-up study. 101 Tg-Ab 
-analysed with the 
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To investigate if the disagreement between the two methods could be associated 
with the long storage time of the frozen serum samples we performed additional Tg 
measurements of 100 Tg-Ab negative serum samples kept frozen from the C2 study 
in 2004-2005. These serum samples were kept frozen for 10 years and were re-
analysed using the same method. A Bland-Altman plot (Fig 6-2) demonstrated an 
overall acceptable agreement between the measurements compared with the results 
found after re-analysing samples with a new method (Fig 6-1).  
 
Fig. 6-2. Bland-Altman plot illustrating the agreement between the Tg values of the serum 
samples from C2 (2004-2005) and the re-measurement of the same serum samples after 10 
years of freezer storage (2015) by the same method (n=100).  
After storage, the Tg values were somewhat lower than the Tg values before storage 
(median 7.3 % lower, 25th-75th percentiles: 15.0 % lower to 0.5 % higher). This 
suggests that the main influence on Tg measurements in the between assay analyses 
was in fact the inter-assay variation and to a smaller degree the relatively long 
storage time. However, all baseline Tg values in Paper III were adjusted 
corresponding to the difference found in the inter-assay analysis and this may have 
over-adjusted baseline Tg values by 7%. This over-adjustment may have influenced 
some results of Paper III where median Tg in Copenhagen might have decreased 
during the follow-up period if the data had not been over-adjusted. However, even 
if the same assay from the same manufacturer was used when concentrations were 
re-measured 10 years after the first measurement, it is difficult to exclude that small 
changes in assay characteristics had occurred over time. Overall, this additional 
analysis suggests that less weight should be put on changes in Tg < 10 % if serum 
samples have been collected many years apart. 
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CHAPTER 7. CONCLUSIONS AND 
PERSPECTIVES 
This thesis illuminates the association between IF and individual changes in thyroid 
volume, thyroid nodularity and serum Tg in an 11-year follow-up investigation 
performed in two regions with different iodine intake at baseline. Baseline 
information was obtained before the Danish mandatory IF of salt commenced in 
year 2000.  
We established that regional residence as a proxy of baseline iodine intake was of 
major importance for the individual changes observed in all three outcome 
measures. This suggests that even small differences in baseline iodine intake play 
an important role for the effect of an IF program. At follow-up the regional 
difference in UIC had disappeared and both regions were classified as mildly iodine 
deficient. Correspondingly, regional differences in both thyroid volume (Paper I) 
and serum Tg (Paper II) had levelled out at follow-up. Contradictory results were 
found regarding thyroid nodules (paper III) where especially lower normalization 
rate of multiple nodules in Aalborg was evident. This may indicate that thyroid 
nodularity is more resistant to an increase in iodine intake compared with thyroid 
volume and serum Tg, and a certain degree of iodine memory may be in action. 
At the follow-up investigation both regions were classified as mildly iodine 
deficient and median Tg among non-users of iodine containing supplements were 
higher than among iodine supplement users. These findings raise the question if a 
moderate increase in the level of iodine added to salt could be beneficial for the 
Danish population. A new cross-sectional investigation with participants from the 
same regions and within the same age and sex groups as in C1a and C2 would give 
valuable information on the Danish iodine status as would a schoolchildren 
investigation preferably performed in eastern Denmark, with the highest iodine 
content of drinking water. 
The results of this thesis underline the importance of regional differences in iodine 
intake prior to an IF program where even relatively small differences in the iodine 
content of drinking water influenced on the individual response to IF. Furthermore, 
UIC were lower in our follow-up investigation compared with the cross-sectional 
investigation performed in 2004-2005 even though the level of iodine added to the 
household and industrial salt (13 µg/g) had not been changed. This stresses the 
importance of persistent monitoring to obtain sustainable iodine sufficiency since 
many factors can influence on the iodine intake in a population. Such factors may 
be changes in dietary habits (e.g. a lower intake of table salt) or in the iodine 
content of food items (e.g. a lower iodine content of dairy products). 
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Our study has no control group (no group without IF) and in principle no 
conclusions regarding causal relations between IF and individual changes in the 
investigated outcome measures can be drawn. However, no previous longitudinal 
investigation has baseline information before the implementation of an IF program. 
Therefore, this investigation gave unique insights into how an IF program 
influences the population at the level of individual inhabitants.   
  
LITERATURE LIST 
(1) Delange F. The disorders induced by iodine deficiency. Thyroid 1994 
Spring;4(1):107-128. 
(2) Zimmermann MB, Jooste PL, Pandav CS. Iodine-deficiency disorders. Lancet 
2008 Oct 4;372(9645):1251-1262. 
(3) Laurberg P, Cerqueira C, Ovesen L, Rasmussen LB, Perrild H, Andersen S, et 
al. Iodine intake as a determinant of thyroid disorders in populations. Best Pract Res 
Clin Endocrinol Metab 2010 Feb;24(1):13-27. 
(4) Kelly FC, Snedden WW. Prevalence and distribution of endemic goitre. In: 
Endemic Goitre. WHO, Geneva; 1960. p. 27-233. 
(5) Rasmussen LB, Andersen S, Ovesen L, Laurberg P. Iodine Intake and Food 
Choice. In: Preedy V, Burrow G, Watson R, editors. Comprehensive Handbook of 
Iodine: Nutritional, Biochemical, Pathological and Therapeutic Aspects. 1st ed.: 
Academic Press/Elsevier; 2009. p. 333-337. 
(6) Vought RL, London WT. Iodine intake, excretion and thyroidal accumulation in 
healthy subjects. J Clin Endocrinol Metab 1967 Jul;27(7):913-919. 
(7) Rasmussen LB, Ovesen L, Christiansen E. Day-to-day and within-day variation 
in urinary iodine excretion. Eur J Clin Nutr 1999 May;53(5):401-407. 
(8) Andersen S, Pedersen KM, Pedersen IB, Laurberg P. Variations in urinary 
iodine excretion and thyroid function. A 1-year study in healthy men. Eur J 
Endocrinol 2001 May;144(5):461-465. 
(9) Andersen S, Karmisholt J, Pedersen KM, Laurberg P. Reliability of studies of 
iodine intake and recommendations for number of samples in groups and in 
individuals. Br J Nutr 2008 Apr;99(4):813-818. 
(10) WHO, UNICEF, ICCIDD. Assessment of iodine deficiency disorders and 
monitoring their elimination. 2007. 3rd edition Geneva: World Health Organization 
(11) Zimmermann M, Saad A, Hess S, Torresani T, Chaouki N. Thyroid ultrasound 
compared with World Health Organization 1960 and 1994 palpation criteria for 
determination of goiter prevalence in regions of mild and severe iodine deficiency. 
Eur J Endocrinol 2000 Dec;143(6):727-731. 
  
(12) Carle A, Krejbjerg A, Laurberg P. Epidemiology of nodular goitre. Influence 
of iodine intake. Best Pract Res Clin Endocrinol Metab 2014 Aug;28(4):465-479. 
(13) Tokuyama T, Yoshinari M, Rawitch AB, Taurog A. Digestion of thyroglobulin 
with purified thyroid lysosomes: preferential release of iodoamino acids. 
Endocrinology 1987 Aug;121(2):714-721. 
(14) Knudsen N, Bulow I, Jorgensen T, Perrild H, Ovesen L, Laurberg P. Serum 
Tg--a sensitive marker of thyroid abnormalities and iodine deficiency in 
epidemiological studies. J Clin Endocrinol Metab 2001 Aug;86(8):3599-3603. 
(15) Spencer CA, Wang CC. Thyroglobulin measurement. Techniques, clinical 
benefits, and pitfalls. Endocrinol Metab Clin North Am 1995 Dec;24(4):841-863. 
(16) Rasmussen LB, Andersson G, Haraldsdottir J, Kristiansen E, Molsted K, 
Laurberg P, et al. Iodine. Do we need an enrichment program in Denmark? Int J 
Food Sci Nutr 1996 Sep;47(5):377-381. 
(17) Pedersen KM, Laurberg P, Nohr S, Jorgensen A, Andersen S. Iodine in 
drinking water varies by more than 100-fold in Denmark. Importance for iodine 
content of infant formulas. Eur J Endocrinol 1999 May;140(5):400-403. 
(18) Rasmussen LB, Larsen EH, Ovesen L. Iodine content in drinking water and 
other beverages in Denmark. Eur J Clin Nutr 2000 Jan;54(1):57-60. 
(19) Andersen S, Pedersen KM, Iversen F, Terpling S, Gustenhoff P, Petersen SB, 
et al. Naturally occurring iodine in humic substances in drinking water in Denmark 
is bioavailable and determines population iodine intake. Br J Nutr 2008 
Feb;99(2):319-325. 
(20) Laurberg P, Jorgensen T, Perrild H, Ovesen L, Knudsen N, Pedersen IB, et al. 
The Danish investigation on iodine intake and thyroid disease, DanThyr: status and 
perspectives. Eur J Endocrinol 2006 Aug;155(2):219-228. 
(21) Fødevareministeriets bekendtgørelse. Bekendtgørelse om tilsætning af jod til 
husholdningssalt og salt i brød og almindeligt bagværk m.v. 29. juni 2000;nr. 627. 
(22) Stanbury JB, Ermans AE, Bourdoux P, Todd C, Oken E, Tonglet R, et al. 
Iodine-induced hyperthyroidism: occurrence and epidemiology. Thyroid 1998 
Jan;8(1):83-100. 
 
  
(23) Zhao W, Han C, Shi X, Xiong C, Sun J, Shan Z, et al. Prevalence of goiter and 
thyroid nodules before and after implementation of the universal salt iodization 
program in mainland China from 1985 to 2014: a systematic review and meta-
analysis. PLoS One 2014 Oct 14;9(10):e109549. 
(24) Ingbar SH, Werner SC. The thyroid : A fundamental and clinical text. 4th ed. 
Hagerstown: Harper and Row; 1978. Section I: The Normal Thyroid:217-241. 
(25) Gärtner R. Autoregulation of Thyroid Growth and Function by Iodine: 
Independent Regulation of the Thyroid Gland by Iodocompounds. In: Preedy VR, 
Burrow GN, Watson RR, editors. Comprehensive Handbook of Iodine: Nutritional, 
Biochemical, Pathological and Therapeutic Aspects. 1st ed.: Academic 
Press/Elsevier; 2009. p. 243-247. 
(26) Rasmussen SN, Hjorth L. Determination of thyroid volume by ultrasonic 
scanning. J Clin Ultrasound 1974 Jun;2(2):143-147. 
(27) Brunn J, Block U, Ruf G, Bos I, Kunze WP, Scriba PC. Volumetric analysis of 
thyroid lobes by real-time ultrasound (author's transl). Dtsch Med Wochenschr 
1981 Oct 9;106(41):1338-1340. 
(28) Gutekunst R, Becker W, Hehrmann R, Olbricht T, Pfannenstiel P. Ultrasonic 
diagnosis of the thyroid gland. Dtsch Med Wochenschr 1988 Jul 8;113(27):1109-
1112. 
(29) Peter HJ, Gerber H, Studer H, Smeds S. Pathogenesis of heterogeneity in 
human multinodular goiter. A study on growth and function of thyroid tissue 
transplanted onto nude mice. J Clin Invest 1985 Nov;76(5):1992-2002. 
(30) Studer H, Peter HJ, Gerber H. Natural heterogeneity of thyroid cells: the basis 
for understanding thyroid function and nodular goiter growth. Endocr Rev 1989 
May;10(2):125-135. 
(31) Laurberg P. Multinodular goitre. 2000; Thyroid International 3, Merck KGaA, 
Darmstadt, Germany. 
(32) Krohn K, Paschke R. Clinical review 133: Progress in understanding the 
etiology of thyroid autonomy. J Clin Endocrinol Metab 2001 Jul;86(7):3336-3345. 
(33) Song Y, Driessens N, Costa M, De Deken X, Detours V, Corvilain B, et al. 
Roles of hydrogen peroxide in thyroid physiology and disease. J Clin Endocrinol 
Metab 2007 Oct;92(10):3764-3773. 
 
  
(34) Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedus L, et al. 
American Association of Clinical Endocrinologists, Associazione Medici 
Endocrinologi, and European Thyroid Association medical guidelines for clinical 
practice for the diagnosis and management of thyroid nodules. J Endocrinol Invest 
2010;33(5 Suppl):1-50. 
(35) Lippolis PV, Tognini S, Materazzi G, Polini A, Mancini R, Ambrosini CE, et 
al. Is elastography actually useful in the presurgical selection of thyroid nodules 
with indeterminate cytology? J Clin Endocrinol Metab 2011 Nov;96(11):E1826-30. 
(36) Mehta RS, Carty SE, Ohori NP, Hodak SP, Coyne C, LeBeau SO, et al. 
Nodule size is an independent predictor of malignancy in mutation-negative 
nodules with follicular lesion of undetermined significance cytology. Surgery 2013 
Oct;154(4):730-6; discussion 736-8. 
(37) Krejbjerg A, Brilli L, Pikelis A, Pedersen HB, Laurberg P. Thyroid 
malignancy markers on sonography are common in patients with benign thyroid 
disease and previous iodine deficiency. J Ultrasound Med 2015 Feb;34(2):309-316. 
(38) Daniel PM, Pratt OE, Roitt IM, Torrigiani G. The release of thyroglobulin 
from the thyroid gland into thyroid lymphatics; the identification of thyroglobulin 
in the thyroid lymph and in the blood of monkeys by physical and immunological 
methods and its estimation by radioimmunoassay. Immunology 1967 
May;12(5):489-504. 
(39) Roitt IM, Torrigiani G. Identification and estimation of undegraded 
thyroglobulin in human serum. Endocrinology 1967 Sep;81(3):421-429. 
(40) Van Herle AJ, Hershman JM, Hornabrook RW, Chopra IJ. Serum 
thyroglobulin in inhabitants of an endemic goiter region of New Guinea. J Clin 
Endocrinol Metab 1976 Sep;43(3):512-516. 
(41) Fenzi GF, Ceccarelli C, Macchia E, Monzani F, Bartalena L, Giani C, et al. 
Reciprocal changes of serum thyroglobulin and TSH in residents of a moderate 
endemic goitre area. Clin Endocrinol (Oxf) 1985 Aug;23(2):115-122. 
(42) Gutekunst R, Smolarek H, Hasenpusch U, Stubbe P, Friedrich HJ, Wood WG, 
et al. Goitre epidemiology: thyroid volume, iodine excretion, thyroglobulin and 
thyrotropin in Germany and Sweden. Acta Endocrinol (Copenh) 1986 
Aug;112(4):494-501. 
 
  
(43) Pedersen KM, Borlum KG, Knudsen PR, Hansen ES, Johannesen PL, 
Laurberg P. Urinary iodine excretion is low and serum thyroglobulin high in 
pregnant women in parts of Denmark. Acta Obstet Gynecol Scand 1988;67(5):413-
416. 
(44) Pedersen KM, Laurberg P, Iversen E, Knudsen PR, Gregersen HE, Rasmussen 
OS, et al. Amelioration of some pregnancy-associated variations in thyroid function 
by iodine supplementation. J Clin Endocrinol Metab 1993 Oct;77(4):1078-1083. 
(45) Laurberg P, Pedersen KM. A sensitive radio-immunoassay for serum 
thyroglobulin--including a correct screening for thyroglobulin autoantibodies. 
Scand J Clin Lab Invest 1987 Nov;47(7):685-689. 
(46) Zimmermann MB. Iodine deficiency. Endocr Rev 2009 Jun;30(4):376-408. 
(47) Häggström M. "Medical gallery of Mikael Häggström 2014". Wikiversity 
Journal of Medicine1 (2). DOI:10.15347/wjm/2014.008. ISSN20018762. - Mainly 
Own work Source image for nucleus derivative: (Public Domain license).  
(48) Ingbar SH, Werner SC. The thyroid : A fundamental and clinical text. 4th ed. 
Hagerstown: Harper and Row; 1978. Section I: The Normal Thyroid:48-74.  
(49) Vejbjerg P, Knudsen N, Perrild H, Laurberg P, Carle A, Pedersen IB, et al. 
Thyroglobulin as a marker of iodine nutrition status in the general population. Eur J 
Endocrinol 2009 Sep;161(3):475-481. 
(50) Knudsen N, Bulow I, Jorgensen T, Laurberg P, Ovesen L, Perrild H. Goitre 
prevalence and thyroid abnormalities at ultrasonography: a comparative 
epidemiological study in two regions with slightly different iodine status. Clin 
Endocrinol (Oxf) 2000 Oct;53(4):479-485. 
(51) Knudsen N, Bulow I, Jorgensen T, Laurberg P, Ovesen L, Perrild H. 
Comparative study of thyroid function and types of thyroid dysfunction in two areas 
in Denmark with slightly different iodine status. Eur J Endocrinol 2000 
Oct;143(4):485-491. 
(52) Vejbjerg P, Knudsen N, Perrild H, Carle A, Laurberg P, Pedersen IB, et al. 
Effect of a mandatory iodization program on thyroid gland volume based on 
individuals' age, gender, and preceding severity of dietary iodine deficiency: a 
prospective, population-based study. J Clin Endocrinol Metab 2007 
Apr;92(4):1397-1401. 
 
  
(53) Rasmussen LB, Jorgensen T, Perrild H, Knudsen N, Krejbjerg A, Laurberg P, 
et al. Mandatory iodine fortification of bread and salt increases iodine excretion in 
adults in Denmark - A 11-year follow-up study. Clin Nutr 2014 Dec;33(6):1033-
1040. 
(54) Knudsen N, Bols B, Bulow I, Jorgensen T, Perrild H, Ovesen L, et al. 
Validation of ultrasonography of the thyroid gland for epidemiological purposes. 
Thyroid 1999 Nov;9(11):1069-1074. 
(55) Wilson B, Van Zyl A. The estimation of iodine in thyroidal amino acids by 
alkaline ashing. S Afr J Med Sci 1967 Oct;32(3):70-82. 
(56) Laurberg P. Thyroxine and 3,5,3'-triiodothyronine content of thyroglobulin in 
thyroid needle aspirates in hyperthyroidism and hypothyroidism. J Clin Endocrinol 
Metab 1987 May;64(5):969-974. 
(57) Berghout A, Wiersinga WM, Smits NJ, Touber JL. Interrelationships between 
age, thyroid volume, thyroid nodularity, and thyroid function in patients with 
sporadic nontoxic goiter. Am J Med 1990 Nov;89(5):602-608. 
(58) Hegedus L. Thyroid size determined by ultrasound. Influence of physiological 
factors and non-thyroidal disease. Dan Med Bull 1990 Jun;37(3):249-263. 
(59) Brown RA, Al-Moussa M, Beck J. Histometry of normal thyroid in man. J Clin 
Pathol 1986 May;39(5):475-482. 
(60) Mahne A, El-Haddad G, Alavi A, Houseni M, Moonis G, Mong A, et al. 
Assessment of age-related morphological and functional changes of selected 
structures of the head and neck by computed tomography, magnetic resonance 
imaging, and positron emission tomography. Semin Nucl Med 2007 Mar;37(2):88-
102. 
(61) Grussendorf M, Reiners C, Paschke R, Wegscheider K, LISA Investigators. 
Reduction of thyroid nodule volume by levothyroxine and iodine alone and in 
combination: a randomized, placebo-controlled trial. J Clin Endocrinol Metab 2011 
Sep;96(9):2786-2795. 
(62) Kahaly G, Dienes HP, Beyer J, Hommel G. Randomized, double blind, 
placebo-controlled trial of low dose iodide in endemic goiter. J Clin Endocrinol 
Metab 1997 Dec;82(12):4049-4053. 
(63) Bland JM, Altman DG. Regression towards the mean. BMJ 1994 Jun 
4;308(6942):1499. 
  
(64) Rasmussen LB, Carle A, Jorgensen T, Knuthsen P, Krejbjerg A, Perrild H, et 
al. Iodine excretion has decreased in Denmark between 2004 and 2010 - the 
importance of iodine content in milk. Br J Nutr 2014 Dec;112(12):1993-2001. 
(65) Markou K, Georgopoulos N, Kyriazopoulou V, Vagenakis AG. Iodine-Induced 
hypothyroidism. Thyroid 2001 May;11(5):501-510. 
(66) Laurberg P, Bulow Pedersen I, Knudsen N, Ovesen L, Andersen S. 
Environmental iodine intake affects the type of nonmalignant thyroid disease. 
Thyroid 2001 May;11(5):457-469. 
(67) Cerqueira C, Knudsen N, Ovesen L, Perrild H, Rasmussen LB, Laurberg P, et 
al. Association of iodine fortification with incident use of antithyroid medication--a 
Danish Nationwide Study. J Clin Endocrinol Metab 2009 Jul;94(7):2400-2405. 
(68) Cerqueira C, Knudsen N, Ovesen L, Laurberg P, Perrild H, Rasmussen LB, et 
al. Nationwide trends in surgery and radioiodine treatment for benign thyroid 
disease during iodization of salt. Eur J Endocrinol 2010 Apr;162(4):755-762. 
(69) Cerqueira C, Knudsen N, Ovesen L, Laurberg P, Perrild H, Rasmussen LB, et 
al. Doubling in the use of thyroid hormone replacement therapy in Denmark: 
association to iodization of salt? Eur J Epidemiol 2011 Aug;26(8):629-635. 
(70) Andersen SL, Sorensen LK, Krejbjerg A, Moller M, Laurberg P. Iodine 
deficiency in Danish pregnant women. Dan Med J 2013 Jul;60(7):A4657. 
(71) Delange F. The role of iodine in brain development. Proc Nutr Soc 2000 
Feb;59(1):75-79. 
(72) Andersen SL, Sorensen LK, Krejbjerg A, Moller M, Laurberg P. Challenges in 
the evaluation of urinary iodine status in pregnancy: the importance of iodine 
supplement intake and time of sampling. Eur Thyroid J 2014 Sep;3(3):179-188. 
(73) Jarlov EA, Hegedus L, Gjorup T, Hansen MJ. Inadequacy of the WHO 
classification of the thyroid gland. Thyroidology 1992 Dec;4(3):107-110. 
(74) Jarlov AE, Nygard B, Hegedus L, Karstrup S, Hansen JM. Observer variation 
in ultrasound assessment of the thyroid gland. Br J Radiol 1993 Jul;66(787):625-
627. 
(75) Park SJ, Park SH, Choi YJ, Kim DW, Son EJ, Lee HS, et al. Interobserver 
variability and diagnostic performance in US assessment of thyroid nodule 
according to size. Ultraschall Med 2012 Dec;33(7):E186-90. 
Iodine is an essential mineral for the synthesis of thyroid hormones. Low 
iodine intake levels are associated with goitre and other iodine deficiency-re-
lated disorders that have affected billions of people worldwide. Until recently 
the iodine intake of many European populations was below the recommend-
ed level and iodine fortification programs are internationally recommended 
to ensure sufficient iodine intake. Denmark was previously iodine deficient 
with regional differences and a mandatory iodine fortification of household 
salt and salt for commercial production of bread was introduced in the year 
2000. A monitoring program entitled the Danish Investigation on Iodine 
Intake and Thyroid Diseases (DanThyr) was initiated before any iodization 
of salt had begun to improve knowledge on how to evaluate iodine status in 
a population and to study the effects of an increase in iodine intake. The aim 
of this PhD thesis was to evaluate individual changes in thyroid related vari-
ables associated with iodine fortification. We chose thyroid volume, thyroid 
nodularity and serum thyroglobulin as indicators of impact and evaluated 
possible changes in an 11-year follow-up investigation performed before and 
after the mandatory iodine fortification of salt in two regions with different 
iodine intake at baseline. The PhD thesis is a part of DanThyr.
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